Results
|
|
21.
|
A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer. [electronic resource] by
- Haura, Eric B
- Ricart, Alejandro D
- Larson, Timothy G
- Stella, Philip J
- Bazhenova, Lyudmila
- Miller, Vincent A
- Cohen, Roger B
- Eisenberg, Peter D
- Selaru, Paulina
- Wilner, Keith D
- Gadgeel, Shirish M
Producer: 20100812
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 16
Availability: No items available.
|
|
|
22.
|
Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer. [electronic resource] by
- Solomon, Benjamin J
- Kim, Dong-Wan
- Wu, Yi-Long
- Nakagawa, Kazuhiko
- Mekhail, Tarek
- Felip, Enriqueta
- Cappuzzo, Federico
- Paolini, Jolanda
- Usari, Tiziana
- Tang, Yiyun
- Wilner, Keith D
- Blackhall, Fiona
- Mok, Tony S
Producer: 20191003
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 36
Availability: No items available.
|
|
|
23.
|
Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer. [electronic resource] by
- Clark, Jeffrey W
- Camidge, D Ross
- Kwak, Eunice L
- Maki, Robert G
- Shapiro, Geoffrey I
- Chen, Isan
- Tan, Weiwei
- Randolph, Sophia
- Christensen, James G
- Ozeck, Mark
- Tang, Yiyun
- Wilner, Keith D
- Salgia, Ravi
Producer: 20200622
In:
Future oncology (London, England) vol. 16
Availability: No items available.
|
|
|
24.
|
First-line crizotinib versus chemotherapy in ALK-positive lung cancer. [electronic resource] by
- Solomon, Benjamin J
- Mok, Tony
- Kim, Dong-Wan
- Wu, Yi-Long
- Nakagawa, Kazuhiko
- Mekhail, Tarek
- Felip, Enriqueta
- Cappuzzo, Federico
- Paolini, Jolanda
- Usari, Tiziana
- Iyer, Shrividya
- Reisman, Arlene
- Wilner, Keith D
- Tursi, Jennifer
- Blackhall, Fiona
Producer: 20141216
In:
The New England journal of medicine vol. 371
Availability: No items available.
|
|
|
25.
|
Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer. [electronic resource] by
- Durairaj, Chandrasekar
- Ruiz-Garcia, Ana
- Gauthier, Eric R
- Huang, Xin
- Lu, Dongrui R
- Hoffman, Justin T
- Finn, Richard S
- Joy, Anil A
- Ettl, Johannes
- Rugo, Hope S
- Zheng, Jenny
- Wilner, Keith D
- Wang, Diane D
Producer: 20180507
In:
Anti-cancer drugs vol. 29
Availability: No items available.
|
|
|
26.
|
Complex renal cysts associated with crizotinib treatment. [electronic resource] by
- Schnell, Patrick
- Bartlett, Cynthia H
- Solomon, Benjamin J
- Tassell, Vanessa
- Shaw, Alice T
- de Pas, Tommaso
- Lee, Soo-Hyun
- Lee, Geon Kook
- Tanaka, Kaoru
- Tan, Weiwei
- Tang, Yiyun
- Wilner, Keith D
- Safferman, Allan
- Han, Ji-Youn
Producer: 20160229
In:
Cancer medicine vol. 4
Availability: No items available.
|
|
|
27.
|
Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014. [electronic resource] by
- Solomon, Benjamin J
- Cappuzzo, Federico
- Felip, Enriqueta
- Blackhall, Fiona H
- Costa, Daniel B
- Kim, Dong-Wan
- Nakagawa, Kazuhiko
- Wu, Yi-Long
- Mekhail, Tarek
- Paolini, Jolanda
- Tursi, Jennifer
- Usari, Tiziana
- Wilner, Keith D
- Selaru, Paulina
- Mok, Tony S K
Producer: 20170721
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34
Availability: No items available.
|
|
|
28.
|
Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer. [electronic resource] by
- Ou, Sai-Hong Ignatius
- Bazhenova, Lyudmila
- Camidge, D Ross
- Solomon, Benjamin J
- Herman, June
- Kain, Tatiana
- Bang, Yung-Jue
- Kwak, Eunice L
- Shaw, Alice T
- Salgia, Ravi
- Maki, Robert G
- Clark, Jeffrey W
- Wilner, Keith D
- Iafrate, A John
Producer: 20110325
In:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 5
Availability: No items available.
|
|
|
29.
|
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases. [electronic resource] by
- Costa, Daniel B
- Shaw, Alice T
- Ou, Sai-Hong I
- Solomon, Benjamin J
- Riely, Gregory J
- Ahn, Myung-Ju
- Zhou, Caicun
- Shreeve, S Martin
- Selaru, Paulina
- Polli, Anna
- Schnell, Patrick
- Wilner, Keith D
- Wiltshire, Robin
- Camidge, D Ross
- Crinò, Lucio
Producer: 20150821
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 33
Availability: No items available.
|
|
|
30.
|
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. [electronic resource] by
- Lennerz, Jochen K
- Kwak, Eunice L
- Ackerman, Allison
- Michael, Michael
- Fox, Stephen B
- Bergethon, Kristin
- Lauwers, Gregory Y
- Christensen, James G
- Wilner, Keith D
- Haber, Daniel A
- Salgia, Ravi
- Bang, Yung-Jue
- Clark, Jeffrey W
- Solomon, Benjamin J
- Iafrate, A John
Producer: 20120203
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29
Availability: No items available.
|
|
|
31.
|
Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer. [electronic resource] by
- Wu, Yi-Long
- Yang, James Chih-Hsin
- Kim, Dong-Wan
- Lu, Shun
- Zhou, Jianying
- Seto, Takashi
- Yang, Jin-Ji
- Yamamoto, Noboru
- Ahn, Myung-Ju
- Takahashi, Toshiaki
- Yamanaka, Takeharu
- Kemner, Allison
- Roychowdhury, Debasish
- Paolini, Jolanda
- Usari, Tiziana
- Wilner, Keith D
- Goto, Koichi
Producer: 20190726
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 36
Availability: No items available.
|
|
|
32.
|
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer. [electronic resource] by
- Wu, Yi-Long
- Lu, Shun
- Lu, You
- Zhou, Jianying
- Shi, Yuan-Kai
- Sriuranpong, Virote
- Ho, James C M
- Ong, Choo Khoon
- Tsai, Chun-Ming
- Chung, Chin-Hee
- Wilner, Keith D
- Tang, Yiyun
- Masters, Elizabeth T
- Selaru, Paulina
- Mok, Tony S
Producer: 20190829
In:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 13
Availability: No items available.
|
|
|
33.
|
Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification. [electronic resource] by
- Ou, Sai-Hong Ignatius
- Kwak, Eunice L
- Siwak-Tapp, Christina
- Dy, Joni
- Bergethon, Kristin
- Clark, Jeffrey W
- Camidge, D Ross
- Solomon, Benjamin J
- Maki, Robert G
- Bang, Yung-Jue
- Kim, Dong-Wan
- Christensen, James
- Tan, Weiwei
- Wilner, Keith D
- Salgia, Ravi
- Iafrate, A John
Producer: 20110920
In:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 6
Availability: No items available.
|
|
|
34.
|
Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer. [electronic resource] by
- Blackhall, Fiona
- Ross Camidge, D
- Shaw, Alice T
- Soria, Jean-Charles
- Solomon, Benjamin J
- Mok, Tony
- Hirsh, Vera
- Jänne, Pasi A
- Shi, Yuankai
- Yang, Pan-Chyr
- Pas, Tommaso De
- Hida, Toyoaki
- Carpeño, Javier De Castro
- Lanzalone, Silvana
- Polli, Anna
- Iyer, Shrividya
- Reisman, Arlene
- Wilner, Keith D
- Kim, Dong-Wan
Publication details: ESMO open 2017
In:
ESMO open vol. 2
Availability: No items available.
|
|
|
35.
|
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. [electronic resource] by
- Butrynski, James E
- D'Adamo, David R
- Hornick, Jason L
- Dal Cin, Paola
- Antonescu, Cristina R
- Jhanwar, Suresh C
- Ladanyi, Marc
- Capelletti, Marzia
- Rodig, Scott J
- Ramaiya, Nikhil
- Kwak, Eunice L
- Clark, Jeffrey W
- Wilner, Keith D
- Christensen, James G
- Jänne, Pasi A
- Maki, Robert G
- Demetri, George D
- Shapiro, Geoffrey I
Producer: 20101105
In:
The New England journal of medicine vol. 363
Availability: No items available.
|
|
|
36.
|
Acquired resistance to crizotinib from a mutation in CD74-ROS1. [electronic resource] by
- Awad, Mark M
- Katayama, Ryohei
- McTigue, Michele
- Liu, Wei
- Deng, Ya-Li
- Brooun, Alexei
- Friboulet, Luc
- Huang, Donghui
- Falk, Matthew D
- Timofeevski, Sergei
- Wilner, Keith D
- Lockerman, Elizabeth L
- Khan, Tahsin M
- Mahmood, Sidra
- Gainor, Justin F
- Digumarthy, Subba R
- Stone, James R
- Mino-Kenudson, Mari
- Christensen, James G
- Iafrate, A John
- Engelman, Jeffrey A
- Shaw, Alice T
Producer: 20130628
In:
The New England journal of medicine vol. 368
Availability: No items available.
|
|
|
37.
|
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration. [electronic resource] by
- Drilon, Alexander
- Clark, Jeffrey W
- Weiss, Jared
- Ou, Sai-Hong Ignatius
- Camidge, D Ross
- Solomon, Benjamin J
- Otterson, Gregory A
- Villaruz, Liza C
- Riely, Gregory J
- Heist, Rebecca S
- Awad, Mark M
- Shapiro, Geoffrey I
- Satouchi, Miyako
- Hida, Toyoaki
- Hayashi, Hidetoshi
- Murphy, Danielle A
- Wang, Sherry C
- Li, Sherry
- Usari, Tiziana
- Wilner, Keith D
- Paik, Paul K
Producer: 20200413
In:
Nature medicine vol. 26
Availability: No items available.
|
|
|
38.
|
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. [electronic resource] by
- Shaw, Alice T
- Kim, Dong-Wan
- Nakagawa, Kazuhiko
- Seto, Takashi
- Crinó, Lucio
- Ahn, Myung-Ju
- De Pas, Tommaso
- Besse, Benjamin
- Solomon, Benjamin J
- Blackhall, Fiona
- Wu, Yi-Long
- Thomas, Michael
- O'Byrne, Kenneth J
- Moro-Sibilot, Denis
- Camidge, D Ross
- Mok, Tony
- Hirsh, Vera
- Riely, Gregory J
- Iyer, Shrividya
- Tassell, Vanessa
- Polli, Anna
- Wilner, Keith D
- Jänne, Pasi A
Producer: 20130628
In:
The New England journal of medicine vol. 368
Availability: No items available.
|
|
|
39.
|
ROS1 rearrangements define a unique molecular class of lung cancers. [electronic resource] by
- Bergethon, Kristin
- Shaw, Alice T
- Ou, Sai-Hong Ignatius
- Katayama, Ryohei
- Lovly, Christine M
- McDonald, Nerina T
- Massion, Pierre P
- Siwak-Tapp, Christina
- Gonzalez, Adriana
- Fang, Rong
- Mark, Eugene J
- Batten, Julie M
- Chen, Haiquan
- Wilner, Keith D
- Kwak, Eunice L
- Clark, Jeffrey W
- Carbone, David P
- Ji, Hongbin
- Engelman, Jeffrey A
- Mino-Kenudson, Mari
- Pao, William
- Iafrate, A John
Producer: 20120504
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30
Availability: No items available.
|
|
|
40.
|
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. [electronic resource] by
- Leonard, John P
- LaCasce, Ann S
- Smith, Mitchell R
- Noy, Ariela
- Chirieac, Lucian R
- Rodig, Scott J
- Yu, Jian Q
- Vallabhajosula, Shankar
- Schoder, Heiko
- English, Patricia
- Neuberg, Donna S
- Martin, Peter
- Millenson, Michael M
- Ely, Scott A
- Courtney, Rachel
- Shaik, Naveed
- Wilner, Keith D
- Randolph, Sophia
- Van den Abbeele, Annick D
- Chen-Kiang, Selina Y
- Yap, Jeffrey T
- Shapiro, Geoffrey I
Producer: 20120716
In:
Blood vol. 119
Availability: No items available.
|